Researchers report the first results from a study testing the revolutionary gene-editing technique known as CRISPR for cutting high cholesterol.
New evidence shows bempedoic acid works to lower cholesterol and reduce the risk of heart attacks, without the muscle pain that some people suffer when taking statins.
